Goldman Sachs’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $75.8M | Buy |
|
|||||
|
2020
Q2 | $5.2M | Sell |
|
|||||
|
2020
Q1 | $6.43M | Buy |
|
|||||
|
2019
Q4 | $10.2M | Buy |
|
|||||
|
2019
Q3 | $4.23M | Sell |
|
|||||
|
2019
Q2 | $6.41M | Sell |
|
|||||
|
2019
Q1 | $7.27M | Buy |
|
|||||
|
2018
Q4 | $4.53M | Sell |
|
|||||
|
2018
Q3 | $7.11M | Buy |
|
|||||
|
2018
Q2 | $5.88M | Buy |
|
|||||
|
2018
Q1 | $6M | Buy |
|
|||||
|
2017
Q4 | $3.06M | Sell |
|
|||||
|
2017
Q3 | $6.13M | Buy |
|
|||||
|
2017
Q2 | $4.67M | Buy |
|
|||||
|
2017
Q1 | $2.06M | Buy |
|
|||||
|
2016
Q4 | $863K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $212K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $392K | Buy |
|